Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

SUMMIT, N.J.--(BUSINESS WIRE)-- Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2025 financial results after market close on February 17, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results.

The press release will be available on the company’s website at investors.kenvue.com.

About Kenvue

Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204640806/en/

Investor Relations:

Sofya Tsinis

Kenvue_IR@Kenvue.com

Media Relations:

Melissa Witt

Media@Kenvue.com

Source: Kenvue